Sedation
Conditions
Interventions
Experimental group:Oral midazolam solution was given orally
Sponsors
The Third Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Age
0.5 Years to 16 Years
Inclusion criteria
Inclusion criteria: 1) 6 months = age = 16 years old, regardless of gender; 2) ASA is classified as I-III; 3) Pediatric patients who require medication sedation before medical examination (such as CT, B-ultrasound, etc.), surgery, or treatment; 4) The guardian and/or patient agree to participate in this trial and voluntarily sign an informed consent form. (The guardian must sign the guardian version of the informed consent form, and children over the age of 8 should sign the minor version of the informed consent form).
Exclusion criteria
Exclusion criteria: 1) allergic to the composition of oral midazolam solution; 2) acute angle-closure glaucoma or untreated open Angle glaucoma; 3) participants participating in an interventional clinical trial; 4) Subjects deemed by the investigator to be ineligible for the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ramsay sedation score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anti-anxiety score;Degree of cooperation score;Satisfaction rating;Pharmacokinetics/pharmacodynamics; | — |
Countries
China
Contacts
Public ContactWen Ouyang
The Third Xiangya Hospital of Central South University
Outcome results
None listed